bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-: an antagonist of bombesin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 122127 |
| SCHEMBL ID | 3045511 |
| MeSH ID | M0359890 |
| Synonym |
|---|
| rc 3095 |
| l-histidinamide, n2-((2,3,4,9-tetrahydro-1h-pyrido(3,4-b)indol-3-yl)carbonyl)-l-glutaminyl-l-tryptophyl-l-alanyl-l-valylglycyl-n-(1-(((1-(aminocarbonyl)-3-methylbutyl)amino)methyl)-3-methylbutyl)-, (1(s),6(s-(r*,r*)))- |
| ccris 6547 |
| rc-3095 |
| bombesin (6-14), tpi(6)-leu(13)-psi(ch2nh)-leu(14)- |
| rc3095 |
| SCHEMBL3045511 |
| PD118690 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 38 (35.85) | 18.2507 |
| 2000's | 34 (32.08) | 29.6817 |
| 2010's | 34 (32.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (1.85%) | 5.53% |
| Reviews | 5 (4.63%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 101 (93.52%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer research, Feb-15, Volume: 54, Issue: 4 | 1994 |
| Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP. International journal of cancer, Oct-09, Volume: 63, Issue: 2 | 1995 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration. Regulatory peptides, Oct-13, Volume: 41, Issue: 3 | 1992 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility. European journal of immunology, Volume: 47, Issue: 4 | 2017 |
| Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. PloS one, Volume: 8, Issue: 6 | 2013 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, Volume: 32, Issue: 1 | 2016 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |